| Secondary |
| Drug Use For Unknown Indication |
31.9% |
| Diabetes Mellitus |
10.6% |
| Hypertension |
10.6% |
| Arrhythmia |
9.2% |
| Chest Pain |
5.7% |
| Agitation |
4.3% |
| Ill-defined Disorder |
4.3% |
| Prophylaxis |
3.5% |
| Product Used For Unknown Indication |
2.8% |
| Encephalitis Herpes |
2.1% |
| Parkinsonism |
2.1% |
| Acute Myocardial Infarction |
1.4% |
| Agitated Depression |
1.4% |
| Back Pain |
1.4% |
| Cardiac Disorder |
1.4% |
| Dementia |
1.4% |
| Dyslipidaemia |
1.4% |
| Emphysema |
1.4% |
| Human Herpesvirus 6 Infection |
1.4% |
| Lung Disorder |
1.4% |
|
| Metabolic Acidosis |
10.5% |
| Renal Failure Acute |
10.5% |
| Thrombocytopenia |
10.5% |
| Hyponatraemia |
7.9% |
| Renal Failure |
7.9% |
| Fall |
5.3% |
| Laryngeal Oedema |
5.3% |
| Lung Infection |
5.3% |
| Melaena |
5.3% |
| Retinopathy |
5.3% |
| Bronchopneumopathy |
2.6% |
| Drug Interaction |
2.6% |
| Drug-induced Liver Injury |
2.6% |
| Extrasystoles |
2.6% |
| Haematoma |
2.6% |
| Hallucination |
2.6% |
| Hepatocellular Injury |
2.6% |
| Hepatomegaly |
2.6% |
| Inappropriate Antidiuretic Hormone Secretion |
2.6% |
| Palpitations |
2.6% |
|
| Concomitant |
| Drug Use For Unknown Indication |
16.2% |
| Hypertension |
14.5% |
| Product Used For Unknown Indication |
14.3% |
| Angina Pectoris |
14.0% |
| Type 2 Diabetes Mellitus |
5.5% |
| Cardiac Failure |
5.5% |
| Acute Myocardial Infarction |
4.6% |
| Breast Cancer |
3.2% |
| Prophylaxis |
3.2% |
| Atrial Fibrillation |
2.5% |
| Non-small Cell Lung Cancer |
2.2% |
| Myocardial Ischaemia |
2.0% |
| Hypercholesterolaemia |
1.8% |
| Hyperlipidaemia |
1.7% |
| Anxiety |
1.5% |
| Cardiac Failure Chronic |
1.5% |
| Myocardial Infarction |
1.5% |
| Coronary Artery Disease |
1.5% |
| Osteoporosis |
1.4% |
| Diabetes Mellitus |
1.3% |
|
| Vomiting |
11.6% |
| Myocardial Infarction |
7.5% |
| Musculoskeletal Chest Pain |
6.8% |
| Death |
6.2% |
| Ventricular Hypertrophy |
6.2% |
| Coronary Artery Stenosis |
4.8% |
| Dyspnoea |
4.8% |
| Rhabdomyolysis |
4.8% |
| Visual Acuity Reduced |
4.8% |
| Weight Decreased |
4.8% |
| Cerebrovascular Accident |
4.1% |
| Drug Interaction |
4.1% |
| Neuroendocrine Carcinoma |
4.1% |
| Pancytopenia |
4.1% |
| Shock |
4.1% |
| Cardiac Failure Acute |
3.4% |
| Dehydration |
3.4% |
| Hyperkalaemia |
3.4% |
| Hyperthyroidism |
3.4% |
| Pyrexia |
3.4% |
|
| Interacting |
| Drug Use For Unknown Indication |
100.0% |
|
|
